RxDoctor Payments DataLook up a doctor →

David Bernard

Nephrology · New York, NYNPI 1518117712

Payments from drug & device makers

$5,998,239in general payments, 2019–2025

Across 397 payments — averaging $15,109 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bavarian Nordic A/s$2M
  • Genentech, Inc.$1.3M
  • AstraZeneca$694K
  • Pfizer$427K
  • Merck$416K
  • GSK$330K
  • plus $881K from 18 others
$232,513in research payments, 2019–2025

Across 34 payments — averaging $6838.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Applied Therapeutics, Inc.$227K
  • Eli Lilly$5K
  • Gilead$902

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,998,239 in reported general payments places this provider in the 95th percentile of 935 nephrology providers in New York.

See all nephrology providers in New York

Other nephrology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →